Synthonics' Corporate Minority Round

Synthonics raised a round of funding on April 16, 2015. Investors include Recipharm.

Synthonics is a specialty pharmaceutical company focused on the discovery, development and licensing of drugs that incorporate our proprietary metal coordination chemistry. Metal coordination entails …

Articles about Synthonics' Corporate Minority Round: